Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
OneMedNet Corporation is implementing a 1-for-10 reverse stock split of its common stock, effective September 29, 2026. The action is intended to bring the company into compliance with Nasdaq's minimum bid price requirement for continued listing. The split will reduce the outstanding share count from approximately 60.1 million to approximately 6.0 million shares.
SkinHealth Systems stockholders approved an amendment to the company's Restated Certificate of Incorporation to implement a reverse stock split of its Class A Common Stock. The approved ratio range is between 1-for-5 and 1-for-20, with the final ratio to be determined by the board of directors.
SHF Holdings (Safe Harbor Financial) has approved a 1-for-12 reverse stock split of its common stock, effective September 30, 2026. The split aims to consolidate every twelve outstanding shares into one share to adjust the trading price on the Nasdaq Stock Market. Stockholders previously approved the measure at a special meeting held in November 2025.
Matinas BioPharma implemented a one-for-fifteen (1:15) reverse stock split of its common stock effective September 28, 2026. The split was previously approved by stockholders at the 2025 annual meeting and is intended to adjust the share price for continued trading on the NYSE American.
Catheter Precision, Inc. will execute a 1-for-10 reverse stock split and change its corporate name to Flyte Aviation, Inc., effective October 5, 2026. The company's common stock will begin trading on a split-adjusted basis on the NYSE American under the new ticker symbol 'VJET'.
VerifyMe, Inc. has implemented a 1-for-10 reverse stock split of its common stock, effective September 29, 2026. The split consolidates every 10 existing shares into one share to adjust the trading price on the Nasdaq Capital Market, while the total number of authorized shares remains unchanged. Additionally, the company adjusted its previously declared special cash dividend from $0.15 to $1.50 per share on a post-split basis, contingent upon the closing of its merger with Open World Ltd.
CDT Equity Inc. has announced a 1-for-25 reverse stock split of its common stock, effective September 28, 2026. The split is intended to increase the per-share price to ensure continued compliance with the Nasdaq minimum bid-price requirement. Trading on a split-adjusted basis is expected to begin on September 29, 2026, reducing the outstanding share count to approximately 1.12 million shares.
Stockholders of Dror Ortho-Design, Inc. approved an amendment to the company's Certificate of Incorporation to effect a reverse stock split of its common stock. The board of directors has the discretion to determine the final ratio within a range of 1-for-2 to 1-for-2,000 and the timing of the split within one year of the approval.
PLAYSTUDIOS announced a 1-for-10 reverse stock split effective September 30, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The company also disclosed it has repurchased 4.3 million shares for $3.0 million during the third quarter of 2026. Split-adjusted trading is expected to begin on October 1, 2026.
Fractyl Health stockholders approved a series of alternate amendments to the company's Certificate of Incorporation to effect a reverse stock split. The Board of Directors has the discretion to select a ratio between 1-for-5 and 1-for-15. The measure was approved at a Special Meeting of Stockholders held on September 24, 2026.
NexGel stockholders approved an amendment to the Certificate of Incorporation to effect a discretionary reverse stock split at a ratio between 1-for-2 and 1-for-20. Stockholders also approved increasing the number of authorized shares of common stock from 25 million to 150 million.
VSee Health, Inc. has filed a Certificate of Amendment to effect a 1-for-80 reverse stock split of its common stock, effective September 23, 2026. The stock will begin trading on a split-adjusted basis on September 24, 2026, under a new CUSIP number. No fractional shares will be issued, with any resulting fractions rounded up to the next whole number.
MariMed Inc. has filed a definitive proxy statement for a special meeting of stockholders to seek approval for a reverse stock split at a ratio between 1-for-50 and 1-for-100. The move is intended to increase the share price to satisfy listing requirements for a potential move to a major U.S. national securities exchange. The special meeting is scheduled for October 28, 2026.
Brightline Interactive announced a 1-for-8 reverse stock split of its common stock effective September 28, 2026. The action is intended to increase the per-share price to regain compliance with the Nasdaq $1.00 minimum bid price requirement and avoid delisting.
Cheetah Net Supply Chain Service Reverse Stock Split
Cheetah Net Supply Chain Service Inc. implemented a 1-for-150 reverse stock split of its Class A and Class B common stock, effective September 21, 2026. The split reduced the outstanding Class A shares from approximately 199.8 million to approximately 1.33 million to adjust the per-share trading price. The stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market on September 28, 2026.
Nauticus Robotics, Inc. has implemented a 1-for-6 reverse stock split of its common stock, effective September 24, 2026. The split is intended to increase the per-share price to regain compliance with the Nasdaq Capital Market's minimum bid price requirement. Shares will begin trading on a split-adjusted basis under the existing ticker 'KITT' on September 25, 2026.
Apimeds Pharmaceuticals US, Inc. implemented a 1-for-10 reverse stock split of its common stock effective July 24, 2026. The split reduced the number of outstanding shares from approximately 15.1 million to 1.5 million and adjusted the par value to $0.001 per share. The company's common stock began trading on a split-adjusted basis on the NYSE American under the symbol 'APUS' at the market open.
Sky Quarry Inc. stockholders approved two separate proposals to authorize the Board of Directors to effect reverse stock splits at ratios ranging from 1-for-2 to 1-for-25. The first split can be implemented within two years, and a second split is authorized to occur after the first, also within a two-year window. Stockholders also approved the company's 2026 Omnibus Incentive Plan during the special meeting.
Stockholders of iPower Inc. approved a reverse stock split at a ratio of up to 1-for-250 to maintain compliance with Nasdaq listing requirements. Additionally, shareholders approved the issuance of up to $10 million in common stock and an amendment to the 2020 Equity Incentive Plan to increase the share reserve to 50 million shares.
Jaguar Health, Inc. effected a 1-for-15 reverse stock split of its issued and outstanding common stock on September 17, 2026. Following the split, the company has approximately 520,088 shares of common stock outstanding. Additionally, the company filed a Certificate of Elimination to remove several series of preferred stock from its charter as no shares of those series remained outstanding.
Profusa, Inc. stockholders approved an amendment to the Certificate of Incorporation to authorize the Board of Directors to effect one or more reverse stock splits at a ratio between 1-for-2 and 1-for-12. The Board has the discretion to implement these splits over the next two years, provided the aggregate ratio does not exceed 1-for-12.
VisionWave Holdings, Inc. is implementing a 1-for-20 reverse stock split of its common stock, effective September 22, 2026. The split is intended to increase the per-share trading price to maintain compliance with Nasdaq's $1.00 minimum bid price requirement. The action will reduce the outstanding share count from approximately 47.5 million to 2.4 million shares.
Wheeler Real Estate Investment Trust Reverse Stock Split
Wheeler Real Estate Investment Trust announced a one-for-nine reverse stock split of its common stock, effective September 21, 2026. The split is intended to reduce the number of outstanding shares from approximately 5.1 million to approximately 568,211 to adjust the market price per share. Trading on a split-adjusted basis will begin on the Nasdaq Capital Market on September 22, 2026.
Matinas BioPharma announced that its Board of Directors has approved a 1-for-15 reverse stock split of its common stock, effective September 28, 2026. The split is intended to help the company maintain its listing on the NYSE American exchange by increasing the per-share trading price. No fractional shares will be issued, and stockholders will instead receive proportional cash payments.
Sunshine Biopharma's majority shareholder, CEO Dr. Steve N. Slilaty, has approved a written consent authorizing the board to effect a reverse stock split at a ratio of up to 1-for-20. The board retains discretion over the final ratio and the timing of the split, which will become effective 20 days after a definitive information statement is mailed to stockholders.
Lion Copper Corp. completed a 1-for-27 reverse stock split and changed its name from Lion Copper and Gold Corp. to reflect its focus on copper assets. The consolidation reduced the share count to approximately 15.98 million shares and was implemented to satisfy the minimum bid price requirement for a planned listing on the Nasdaq Capital Market.
Bryn Inc. announced a 1-for-100,000 reverse stock split of its common stock effective September 23, 2026. In conjunction with the split, the company will change its name to MEDO Technologies, Inc. and expects to trade under the new symbol 'MEDO' on the OTCID Market starting September 24, 2026.
Tessera Defense and Homeland Security Inc. (formerly BiomX Inc.) implemented a one-for-ten reverse stock split effective September 9, 2026, to consolidate its share count and adjust its trading price. Alongside the split, the company rebranded from BiomX Inc. and changed its ticker symbol from PHGE to HLSQ on the NYSE American. The company also filed an updated corporate presentation and CEO letter outlining its strategic shift toward a unified security platform for critical infrastructure.
Jaguar Health is implementing a 1-for-15 reverse stock split of its common stock, effective September 17, 2026. The move is intended to bring the company back into compliance with Nasdaq's minimum bid price listing standards. Every 15 shares of existing common stock will be consolidated into one share, with no change to the par value or total authorized shares.
Impact Biomedical Inc. announced a 1-for-12.62 reverse stock split effective September 23, 2026, reducing outstanding shares from approximately 107.8 million to 8.5 million. The split is intended to regain compliance with NYSE American listing requirements and facilitate its proposed merger with Zoar Limited. Following the split and merger closing, Impact stockholders are expected to receive one share of Zoar Limited for every one share of Impact common stock held.